Brandi Roberts, Chief Financial Officer at Definium Therapeutics, Inc. (DFTX), sold 3,013 shares at $45.03 ($136K) on 2026-06-25, disclosed to the SEC on 2026-06-26.
Scheduled sale ($136k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RVA.AX | BUY | 2018-07-02 | $8K | — | Filing → |
| MSTX | BUY | 2015-03-30 | $19K | — | Filing → |